EB1A Sample Cases

EB1A-387: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, cell biology, and oncology, working at a private research institute in the United States. He earned a M.S. in Human Pathology at Aix-Marseille University and a Ph.D.  in Cancer Biology at the Cancer Research Center of Marseille in France. The petitioner published 17 research papers. These publications were cited about 1200 times. The petition was filed in 2024 and approved three months later (NSC, No RFE, premium processing).

EB1A-386: The petitioner/beneficiary was a well-established scientist with strong expertise in social epidemiology, working at a medical school in the United States. She earned a Ph.D. in Social Epidemiology at Harvard University. The petitioner published 52 research papers. These publications were cited about 2000 times. The petition was filed in 2025 and approved three weeks later (TSC, No RFE, premium processing).

EB1A-385: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, cell biology, and immunology, working at a medical school in the United States. She earned a Ph.D. in in Immunology and Microbiology at the University of Massachusetts Medical School, Worcester. The petitioner published nine research papers. These publications were cited about 740 times. The petition was filed in 2024 and approved three weeks later (TSC, No RFE, premium processing).

EB1A-384: The petitioner/beneficiary was a well-established scientist and engineer with strong expertise in physics, mechanics and petroleum engineering., working at a world-leading oil and gas company in the United States. He earned a Ph.D. in Solid Mechanics at the Institute of Strength Physics and Materials Science of Russian Academy of Sciences. The petitioner published 23 research papers and filed 7 patent applications. These publications were cited about 710 times. The petition was filed in 2024 and approved three weeks later (TSC, No RFE, premium processing).

EB1A-383: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, cell biology and neuroscience, working at a medical school in the United States. He earned a Ph.D. in Biochemistry at the University of Hong Kong. The petitioner published 14 journal research articles. These publications were cited about 708 times. The petition was filed in 2024 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-382: The petitioner/beneficiary was a well-established scientist and engineer with strong expertise in mathematics, physics, and petroleum engineering., working as a Senior Research Scientist at a world leading oil and gas company in the United States. He earned both M.S. and Ph.D. in Theoretical Physics in Russia. The petitioner published 16 journal research articles and filed seven patent applications. These publications were cited about 673 times. The petition was filed in 2024 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-381: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, biology and immunology, working as a Principal Investigator at a private research institute in the United States. She earned a M.S. in Molecular Biology at University of the Studies of Padova in Italy and a Ph.D. in Virology and Immunology at the University of Liege in Belgium. The petitioner published 27 journal research articles. These publications were cited about 2,311 times. The petition was filed in 2024 and approved 9 days later (NSC, No RFE, premium processing).

EB1A-380: The petitioner/beneficiary was a well-established computer scientist and engineer, working at a global high-tech in a foreign country (seeking to transfer to the United States). He earned an M.S. in Information Science and Engineering at Fudan University in China. The petitioner published 109 conference research articles and filed 34 patent applications. These publications were cited about 6,000 times. The petition was filed in 2024 and approved 18 days later (NSC, No RFE, premium processing).

EB1A-379: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, virology, immunology, and vaccine development, working at a Federal research institute  in the United States. She earned a Ph.D. in Biological Science at Florida State University. The petitioner published 10 journal research articles. These publications were cited about 1,275 times. The petition was filed in 2024 and approved three months later (TSC, After RFE, premium processing).

EB1A-378: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, and cell biology, working at a cancer research hospital in the United States. He earned a Ph.D. in Cell and Molecular Biology at the University of Pennsylvania. The petitioner published 14 journal research articles. These publications were cited about 1,146 times. The petition was filed in 2024 and approved 15 days later (TSC, No RFE, premium processing).

EB1A-377: The petitioner/beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, and cell biology, working at a medical school in the United States. He earned a Doctor of Natural Science in Biotechnology at Peking University in China. The petitioner published six journal research articles. These publications were cited about 603 times. The petition was filed in 2024 and approved 50 days later (TSC, After RFE, premium processing).

EB1A-376: The petitioner/beneficiary was a well-established scientist and scholar in computer science and technology, working as a professor in Canada (received a job offer from a US university). He earned a Ph.D. in Electrical Engineering and Computer Science at Massachusetts Institute of Technology. The petitioner published 64 journal and conference research articles. These publications were cited about 4,422 times. The petition was filed in 2024 and approved 15 days later (NSC, No RFE, premium processing).

EB1A-375: The petitioner/beneficiary was a well-established computer scientist and engineer with strong expertise in computer vision, computer graphics, deep learning and artificial intelligence, working at a global high tech company in the United States. He earned a Ph.D. in Computer Science at Cornell University in the United States. The petitioner published 19 journal and conference research articles. These publications were cited about 2,276 times. The petition was filed in 2024 and approved 19 days later (NSC, No RFE, premium processing).

EB1A-374: The petitioner/beneficiary was a well-established scientist with strong expertise in bioinformatics, genetics and genomics., working at a medical school in the United States. She earned a Ph.D. in Bioinformatics at Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China. The petitioner published eight journal research articles. These publications were cited about 1,235 times. The petition was filed in 2024 and approved 17 days later (NSC, No RFE, premium processing).

EB1A-373: The petitioner/beneficiary was a well-established scientist and scholar in bioinformatics and computational biology, working at a public university in the United States. He earned an M.S. in Electrical and Electronics Engineering at the University of Teknogi PETRONAS in Malaysia, and a Ph.D. in Computer Engineering at Bikent University in Turkey. The petitioner published 34 journal and conference research articles. These publications were cited about 2,209 times. The petition was filed in 2024 and approved 50 days later (TSC, After RFE, premium processing).

EB1A-372: The petitioner/beneficiary was a well-established scientist and scholar in biochemistry, molecular biology and cell biology, working as a Principal Investigator at a Federal research institute. He earned a Ph.D. in Life and Biomolecualr Sciences at The Open University in the United Kingdom. The petitioner published 21 journal research articles. These publications were cited about 1,869 times. The petition was filed in 2024 and approved 50 days later (TSC, After RFE, premium processing).

EB1A-371: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, cell biology, and neuroscience). She worked as a scientist at a medical school in the United States. The petitioner earned her Ph.D. in Neuroscience in Belgium. She published 11 journal research articles. These publications were cited about 705 times. The petition was filed in 2024 and approved eight days later (NSC, No RFE, premium processing).

EB1A-370: The petitioner/beneficiary was a statistical scientist (mathematics and biostatistics). He worked as an assistant professor at a medical school in the United States. The petitioner earned his Ph.D. in Biostatistics in the United States. He published 31 journal research articles. These publications were cited about 833 times. The petition was filed in 2024 and approved one week later (TSC, No RFE, premium processing).

EB1A-369: The petitioner/beneficiary was a biomedical scientist (biophysics, medical imaging, bioinformatics). He worked as a scientist at a medical school in the United States. The petitioner earned his Ph.D. in Taiwan. He published 28 journal research articles. These publications were cited about 1,328 times. The petition was filed in 2024 and approved four months later (NSC, No RFE, premium processing).

EB1A-368: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, microbiology, and immunology). He worked as a scientist at a medical school in the United States. The petitioner earned his Ph.D. in Genetics and  Molecular Biology in Brazil. He published 22 journal research articles. These publications were cited about 2,500 times. The petition was filed in 2023 and approved nine months later (NSC, No RFE).

EB1A-367: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, and immunology). She worked as a scientist at a very famous university in the United States. The petitioner earned both M.D. and Ph.D. in China. She published 48 journal research articles. These publications were cited over 10,000 times. The petition was filed in 2023 and approved nine months later (NSC, No RFE).

EB1A-366: The petitioner/beneficiary was a biomedical scientist (ophthalmology and retina biology). He worked as a scientist at a medical school in the United States. The petitioner earned his Ph.D. in Neuro-ophthalmology  in the United Kingdom. He published 16 journal research articles. These publications were cited about 555 times. The petition was filed in 2024 and approved three weeks later (NSC, premium processing, No RFE).

EB1A-365: The petitioner/beneficiary was a biomedical scientist (genetics, biochemistry, molecular biology, cell biology, forensic science, and tissue engineering ). He worked as a scientist at a medical school in the United States. The petitioner earned his Ph.D. in Forensic Genetics  in China. He published over 50 journal research articles. These publications were cited about 900 times. The petition was filed in 2024 and approved one month later (NSC, premium processing, No RFE).

EB1A-364: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, cell biology, developmental biology, and regenerative medicine). She worked as a scientist at a medical school in the United States. The petitioner earned her Ph.D. in Biochemistry and Molecular Biology in China. She published over 28 journal research articles. These publications were cited about 3,100 times. The petition was filed in 2024 and approved two weeks later (TSC, premium processing, No RFE).

EB1A-363: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, cell biology, and infectious diseases). She worked as a scientist at a medical school in the United States. The petitioner earned her Ph.D. in Microbiology in China. She published over 16 journal research articles. These publications were cited about 2,680 times. The petition was filed in 2024 and approved two weeks later (TSC, premium processing, No RFE).

EB1A-362: The petitioner/beneficiary was a medical scientist (biochemistry, molecular biology, cell biology, pharmacology, and cardiovascular diseases). She worked as a full professor in China (but was invited to join a lab in the United States). The petitioner earned both M.D. and Ph.D. in China. She published over 26 journal research articles. These publications were cited about 1,400 times. The petition was filed in 2024 and approved three months later (TSC, premium processing, after RFE).

EB1A-361: The petitioner/beneficiary was a biomedical scientist (chemistry, biophysics, and biochemistry). He worked as an assistant professor at university in the United States. The petitioner earned his Ph.D. in Chemistry in the United States. He published over 24 journal research articles. These publications were cited about 1,878 times. The petition was filed in 2024 and approved 10 days later (NSC, premium processing, No RFE).

EB1A-360: The petitioner/beneficiary was a computer scientist (computer and information science, software development, artificial intelligence, etc.). He worked as senior scientist and manager at a global technology company in China. The petitioner earned his Ph.D. in China. He published over 130 research articles and filed over 30 patent applications. These publications were cited about 9,000 times. The petition was filed in 2024 and approved 10 days later (NSC, premium processing, No RFE).

EB1A-359: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, genetics). He worked as at a biotechnology company in the United States. The petitioner earned his Ph.D. in Germany. He published five journal research articles. These publications were cited about 1,049 times. The petition was filed in 2024 and approved nine days later (TSC, premium processing, No RFE).

EB1A-358: The petitioner/beneficiary was a medical scientist (cancer, surgery, liver transplantation). He worked as at a medical school in the United States. The petitioner earned his M.D. in China. He published 28 journal research articles. These publications were cited about 782 times. The petition was filed in 2024 and approved two weeks later (NSC, premium processing, No RFE).

EB1A-357: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, microbiology, immunology, infectious diseases). She worked as at a private research institute in the United States. The petitioner earned his Ph.D. in Italy. He published 21 journal research articles. These publications were cited about 1,500 times. The petition was filed in 2024 and approved four days later (NSC, premium processing, No RFE).

EB1A-356: The petitioner/beneficiary was a biomedical scientist (cell biology, cancer research). He worked as at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 23 journal research articles. These publications were cited about 2,300 times. The petition was filed in 2023 and approved ten months later (TSC, No RFE).

EB1A-355: The petitioner/beneficiary was a biomedical scientist (immunology, neuroscience, neuroimmunology, Alzheimer's disease). He worked as at a pharmaceutical company in the United States. The petitioner earned his Ph.D. in Germany. He published 11 journal research articles. These publications were cited about 2,400 times. The petition was filed in 2024 and approved one week later (NSC, premium processing, No RFE).

EB1A-354: The petitioner/beneficiary was a biomedical scientist (genetics, biochemistry, cell biology, molecular biology). He worked as at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 18 journal research articles. These publications were cited about 780 times. The petition was filed in 2024 and approved one week later (TSC, premium processing, No RFE).

EB1A-353: The petitioner/beneficiary was a biological scientist (biochemistry, molecular biology, cell biology, neuroscience). He worked at a medical school in the United States. The petitioner earned his Ph.D. in Japan. He published 16 journal research articles. These publications were cited about 1350 times. The petition was filed in 2023 and approved ten months later (TSC, No RFE).

EB1A-352: The petitioner/beneficiary was a biological scientist (biochemistry, cell biology, develpmental biology, regenerative medicine). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China. He published seven journal research articles. These publications were cited over 577 times. The petition was filed in 2024 and approved 11 days later (TSC, premium processing, No RFE).

EB1A-351: The petitioner/beneficiary was a biological scientist (biochemistry, cell biology, lipid biology). He worked as an Full Professor at a medical school in the United States. The petitioner earned his Ph.D. in the United States. He published 120 journal research articles. These publications were cited over 10,000 times. The petition was filed in 2024 and approved eight days later (TSC, premium processing, No RFE).

EB1A-350: The petitioner/beneficiary was a computer scientist (computer and information science and technology, artificial intellegence, natural language processing, machine learning). He worked as an Assistant Professor at a public university in the United States. The petitioner earned his Ph.D. in the United States. He published 21 journal research and conference research articles. These publications were cited about 820 times. The petition was filed in 2024 and approved one week later (NSC, premium processing, No RFE).

EB1A-349: The petitioner/beneficiary was a computer scientist (computer and information science and technology). He worked at a global high-tech company in the United States. The petitioner earned his Ph.D. in the United States. He published 11 conference research articles. These publications were cited about 1878 times. The petition was filed in 2023 and approved five months later (NSC, regular filing +premium processing, No RFE).

EB1A-348: The petitioner/beneficiary was a computer scientist (computer and information science and technology). He worked as an Assistant Professor at a public university in the United States. The petitioner earned his Ph.D. in the United States. He published 37 journal research and conference research articles. These publications were cited about 2600 times. The petition was filed in 2023 and approved four months later (NSC, regular filing +premium processing, No RFE).

EB1A-347: The petitioner/beneficiary was a chemical scientist (chemistry, glycobiology, drug development). He worked at a pharmaceutical company in the United States. The petitioner earned his Ph.D. in the United States. He published 18 journal research articles. These publications were cited about 565 times. The petition was filed in 2023 and approved ten days later (TSC, premium processing, No RFE).

EB1A-346: The petitioner/beneficiary was a medical scientist (liver diseases, metabolic disorders ). She worked at a private medical school in the United States. The petitioner earned her Ph.D. in China. She published 11 journal research articles. These publications were cited about 336 times. The petition was filed in 2023 and approved two months later (NSC, premium processing, No RFE; the petitioner previously filed an NIW I-140 which was also approved).

EB1A-345: The petitioner/beneficiary was a medical scientist (biochemistry, molecular biology, cell biology, immunology and cardiovascular diseases). She worked at a public university in the United States. The petitioner earned her Ph.D. in China. She published 16 journal research articles. These publications were cited about 720 times. The petition was filed in 2023 and approved two weeks later (TSC, premium processing, No RFE).

EB1A-344: The petitioner/beneficiary was a medical scientist (biochemistry, molecular biology, nephrology, kidney disease and cancer). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 60 journal research articles. These publications were cited about 1,473 times. The petition was filed in 2023 and approved six months later (NSC, After RFE).

EB1A-343: The petitioner/beneficiary was a medical scientist (biochemistry, molecular biology, cell biology and cancer research). She worked at a medical school in the United States. The petitioner earned her Ph.D. in Japan. She published 12 journal research articles. These publications were cited about 674 times. The petition was filed in 2023 and approved one week later (TSC, No RFE, premium processing).

EB1A-342: The petitioner/beneficiary was a biological scientist (biochemistry, molecular biology, structural biology). She worked at a national research institute in the United States. The petitioner earned her Ph.D. in the United States. She published 20 journal research articles. These publications were cited about 825 times. The petition was filed in 2023 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-341: The petitioner/beneficiary was a medical scientist (virology, infectious diseases, influenza viruses). He worked at a public university in the United States. The petitioner earned his Ph.D. in China. He published 12 journal research articles. These publications were cited about 1,194 times. The petition was filed in 2023 and approved six weeks later (NSC, No RFE, premium processing).

EB1A-340: The petitioner/beneficiary was a medical scientist (tissue engineering, stem cell biology, biomaterials, organoids). He worked at a private university in the United States. The petitioner earned his Ph.D. in Japan. He published 17 journal research articles. These publications were cited about 873 times. The petition was filed in 2023 and approved one month later (NSC, No RFE, premium processing).

EB1A-339: The petitioner/beneficiary was a medical scientist (cancer research, immunology). He worked at a Federal research institute (NIH) in the United States. The petitioner earned his Ph.D. in China. He published 12 journal research articles. These publications were cited about 633 times. The petition was filed in 2022 and approved nine months later (TSC, No RFE, premium processing).

EB1A-338: The petitioner/beneficiary was an environmental scientist (environmental science, analytical chemistry, and metabolomics). She worked at a public university in the United States. The petitioner earned her Ph.D. in the United States. She published 14 journal research articles. These publications were cited about 800 times. The petition was filed in 2023 and approved five months later (NSC, after RFE, premium processing).

EB1A-337: The petitioner/beneficiary was a materials scientist (engineering of advanced materials). He worked at a private university in the United States. The petitioner earned his Ph.D. in the United States. He published 28 journal research articles. These publications were cited about 1, 052 times. The petition was filed in 2023 and approved nine days later (NSC, No RFE, premium processing).

EB1A-336: The petitioner/beneficiary was a medical scientist (cell and molecular biology, mitochondrial biology and toxicology, gene therapy). She worked at a pharmaceutical company in the United States. The petitioner earned her Ph.D. in Portugal. She published 25 journal research articles. These publications were cited about 1, 120 times. The petition was filed in 2023 and approved one week later (TSC, No RFE, premium processing).

EB1A-335: The petitioner/beneficiary was a biological scientist (bioinformatics, genomics, computational biology, systems biology). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 46 journal research articles. These publications were cited about 3,164 times. The petition was filed in 2023 and approved one week later (NSC, No RFE, premium processing).

EB1A-334: The petitioner/beneficiary was a mathematician (biostatistics, medical data analysis). She worked as a tenure-track assistant professor at a famous private university in the United States. The petitioner earned her Ph.D. in the United States. She published 50 journal research articles. These publications were cited about 640 times. The petition was filed in 2023 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-333: The petitioner/beneficiary was a biological scientist (biochemistry, plant molecular biology, neuroscience). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 30 journal research articles. These publications were cited over 1,600 times. The petition was filed in 2023 and approved one week later (TSC, No RFE, premium processing).

EB1A-332: The petitioner/beneficiary was a medical scientist (biomedical engineering, phototherapy, neurobiology, magnetic resonance imaging). He worked at a Federal research institute in the United States. The petitioner earned his Ph.D. in China. He published 21 journal research articles. These publications were cited about 845 times. The petition was filed in 2023 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-331: The petitioner/beneficiary was a medical scientist (molecular biology, biochemistry, neuroscience). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China. He published 10 journal research articles. These publications were cited about 606 times. The petition was filed in 2023 and approved two months later (TSC, after Notice of Intent to Deny; premium processing).

EB1A-330: The petitioner/beneficiary was a medical scientist (molecular biology, metabolism, neuroscience). She worked at a medical school in the United States. The petitioner earned her Ph.D. in the United States. She published 14 journal research articles. These publications were cited about 900 times. The petition was filed in 2023 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-329: The petitioner/beneficiary was a medical scientist (microbiology, genomics, bioinformatics). He worked at a research hospital in the United States. The petitioner earned his Ph.D. in Hong Kong and published 45 journal research articles. These publications were cited over 2,800 times. The petition was filed in 2023 and approved ten days later (NSC, No RFE, premium processing).

EB1A-328: The petitioner/beneficiary was a neuroscientist (neuroscience, visual and olfactory sensory transductions). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China and published 16 journal research articles. These publications were cited over 533 times. The petition was filed in 2023 and approved eight days later (TSC, No RFE, premium processing).

EB1A-327: The petitioner/beneficiary was a medical scientist (infectious disease, immunology, COVID-19). She worked at a private research institute in the United States. The petitioner earned her Ph.D. in Italy and published 89 journal research articles. These publications were cited over 15,000 times. The petition was filed in 2023 and approved eight days later (NSC, No RFE, premium processing).

EB1A-326: The petitioner/beneficiary was a biological scientist (neuroscience, stem cells, neurodegenerative disease models ). She worked at a medical school in the United States. The petitioner earned her Ph.D. in China and published 10 journal research articles. These publications were cited about 480 times. The petition was filed in 2022 and approved ten days later (NSC, No RFE, premium processing).

EB1A-325: The petitioner/beneficiary was a computer/biological scientist (bioinformatics, computer science, machine learning technology). He worked at a private research institute in the United States. The petitioner earned both M.S. and Ph.D. degrees in the United States and published 26 journal research articles. These publications were cited about 3,600 times. The petition was filed in 2022 and approved three months later (TSC, after RFE, premium processing).

EB1A-324: The petitioner/beneficiary was a biological scientist (insect biology, plant biology, developmental biology, medical research). She worked at a public university/medical school in the United States. The petitioner earned his Ph.D. in China and published 13 journal research articles. These publications were cited about 491 times. The petition was filed in 2022 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-323: The petitioner/beneficiary was a biomedical scientist (biochemistry, cell biology, microbiology, immunology). He worked at a medical school in the United States. The petitioner earned his Ph.D. in China and published 38 journal research articles. These publications were cited about 1,500 times. The petition was filed in 2022 and approved 7 days later (NSC, No RFE, premium processing).

EB1A-322: The petitioner/beneficiary was a biomedical scientist (molecular biology, biochemistry, cell biology, genetics). She worked at a medical school in the United States. The petitioner earned her Ph.D. in China and published 38 journal research articles. These publications were cited about 2,600 times. The petition was filed in 2022 and approved six months later (TSC, After RFE, premium processing after pending for a few months).

EB1A-321: The petitioner/beneficiary was a computer and information scientist (artificial intelligence, cybersecurity applications, deep learning). He worked at a public university in the United States. The petitioner earned his Ph.D. in the United States and published 22 journal and conference research articles. These publications were cited about 790 times. The petition was filed in 2022 and approved 4 days later (NSC, No RFE, premium processing).

EB1A-320: The petitioner/beneficiary was a biomedical scientist (cancer biology, biochemistry, cell biology). He worked at a medical school in the United States. The petitioner earned his Ph.D. in Canada and published 15 journal research articles. These publications were cited about 780 times. The petition was filed in 2022 and approved 11 days later (NSC, No RFE, premium processing).

EB1A-319: The petitioner/beneficiary was a statistical scientist (biostatistics, COVID-19) working at a US medical school. She earned her Ph.D. in the United States and published 17 journal research articles. These publications were cited about 500 times. The petition was filed in 2022 and approved several months later (TSC, RFE, premium processing).

EB1A-318: The petitioner/beneficiary was a biomedical scientist (cancer metabolism) working at a US medical school. She earned her Ph.D. in Canada and published 28 journal research articles. These publications were cited about 2,300 times. The petition was filed in 2022 and approved several days later (TSC, No RFE, premium processing).

EB1A-317: The petitioner/beneficiary was a biological scientist (plant science, molecular biology, cell biology, genetics) working at a US medical school. He earned his Ph.D. in Genetics in China and published 14 journal research articles. These publications were cited about 530 times. The petition was filed in 2022 and approved one week later (TSC, No RFE, premium processing).

EB1A-316: The petitioner/beneficiary was a biomedical scientist (bioinformatics, genomics, genetics) working at a US medical school. He earned his Ph.D. in Biology in China and published 24 journal research articles. These publications were cited about 640 times. The petition was filed in October 2020 and approved in June 2022 (TSC, No RFE).

EB1A-315: The petitioner/beneficiary was a medical scientist (pharmacology, toxicology) working at a US medical school. She earned her Ph.D. in the United States and published 31 journal research articles. These publications were cited about 900 times. The petition was filed in 2022 and approved 10 days later (TSC, No RFE, premium processing).

EB1A-314: The petitioner/beneficiary was a medical scientist (genetics, genetic disease) working at a US medical school. She earned her M.D. and Ph.D. in China and published 34 journal research articles. These publications were cited over 1,300  times. The petition was filed in 2021 and approved eight months later (TSC, No RFE, premium processing).

EB1A-313: The petitioner/beneficiary was a medical scientist (infectious disease, immune disease, COVID-19) working at a US research institute. She earned her M.D. and Ph.D. in China and published 15 journal research articles. These publications were cited over 1,160  times. The petition was filed in 2022 and approved one week later (TSC, No RFE, premium processing).

EB1A-312: The petitioner/beneficiary was a marine scientist (physical oceanography, modeling) working at a US public University. He earned his Ph.D. in China and published 21 journal research articles. These publications were cited over 600  times. The petition was filed in 2022 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-311: The petitioner/beneficiary was a medical scientist (genomics, bioinformatics, drug development, cancer research, systems biology) working at a US research institute. She earned her Ph.D. in China and published 25 journal research articles. These publications were cited over 1,300  times. The petition was filed in 2022 and approved one week later (NSC, No RFE, premium processing).

EB1A-310: The petitioner/beneficiary was a biological scientist (structural biology, biochemistry, molecular biology) working at a US research institute. He earned his Ph.D. in China and published 14 journal research articles. These publications were cited about 409 times. The petition was filed in 2021 and approved ten months later (TSC, No RFE).

EB1A-309: The petitioner/beneficiary was a biological scientist (genomics, bioinformatics, evolution, neuroscience) working at a US public university. He earned his Ph.D. in China and published 20 journal research articles. These publications were cited over 1,000 times. The petition was filed in 2021 and approved five months later (NSC, after RFE, premium processing).

EB1A-308: The petitioner/beneficiary was a medical scientist (molecular biology, cell biology) working at a US medical school. He earned his Ph.D. in China and published 18 journal research articles. These publications were cited about 1,300  times. The petition was filed in 2022 and approved one week later (TSC, No RFE, premium processing).

EB1A-307: The petitioner/beneficiary was a medical scientist (cancer research, COVID-19) working at a US research institute. She earned her Ph.D. in China and published 18 journal research articles. These publications were cited over 900 times. The petition was filed in 2022 and approved one week later (NSC, No RFE, premium processing).

EB1A-306: The petitioner/beneficiary was a medical scientist (immunology) working at a US research institute. She earned her Ph.D. in China and published 29 journal research articles. These publications were cited over 1,800 times. The petition was filed in 2021 and approved two weeks later (TSC, No RFE, premium processing).

EB1A-305: The petitioner/beneficiary was a bioinformatic scientist (genetics, genomics, computational biology, genome analysis) working at a US medical school. She earned her Ph.D. in the United States and published 10 journal research articles. These publications were cited over 650 times. The petition was filed in 2020 and approved 11 months later (TSC, No RFE).

EB1A-304: The petitioner/beneficiary was a biomedical scientist (stem cell biology) working at a US national research institute. He earned his Ph.D. in China and published 11 journal research articles. These publications were cited about 630 times. The petition was filed in 2021 and approved one week later (TSC, NO RFE, with the request of premium processing).

EB1A-303: The petitioner/beneficiary was a biomedical scientist (developmental biology, neuroscience) working at a US medical school. He earned his Ph.D. in India and published 18 journal research articles. These publications were cited over 820 times. The petition was filed in 2021 and approved two weeks later (TSC, NO RFE, with the request of premium processing).

EB1A-302: The petitioner/beneficiary was a biomedical scientist (developmental biology, cell biology, stem cell biology) working at a US medical school. He earned his Ph.D. in China and published 13 journal research articles. These publications were cited about 500 times. The petition was filed in 2021 and approved two weeks later (TSC, NO RFE, with the request of premium processing).

EB1A-301: The petitioner/beneficiary was a bioinformatic scientist (developing tools for protein and genome analysis) working at a US medical school. He earned his Ph.D. in the United States and published eight journal research articles. These publications were cited over 600 times. The petition was filed in 2021 and approved two months later (NSC, after RFE, with the request of premium processing).

EB1A-300: The petitioner/beneficiary was a chemical scientist (biomass conversion, biofuel) working at a US medical school. He earned his Ph.D. in India and published 14 journal research articles. These publications were cited about 800 times. The petition was filed in 2020 and approved two months later (NSC, after RFE, with the request of premium processing).

EB1A-299: The petitioner/beneficiary was a biomedical scientist (cancer research, glioblastoma) and worked at a US medical school. He earned his Ph.D. and M.D. in China and published over 21 journal research articles. These publications were cited over 600 times. The petition was filed in 2020 and approved four months later (TSC, no RFE, with the request of premium processing).

EB1A-298: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. She earned her Ph.D. in China and published over 20 journal research articles. These publications were cited over 600 times. The petition was filed in 2019 and approved 18 months later (After RFE).

EB1A-297: The petitioner/beneficiary was a bioinformatics scientist (bioinformatics, genomics, genetics, biotechnology) and worked at a US biotechnology company. He earned his Ph.D. in the United States and published 14 journal research articles. These publications were cited over 1300 times. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-296: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school and research hospital. She earned her Ph.D. in China and published over ten journal research articles. These publications were cited over 400 times. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-295: The petitioner/beneficiary was a chemical scientist (chemical compound synthesis) and worked at a small US chemical company. He earned his Ph.D. in the United States and published ten journal research articles. These publications were widely cited by others. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-294: The petitioner/beneficiary was a biomedical scientist (psychology) and worked at a US medical school. She earned her Ph.D. in the United States and published 11 journal research articles. These publications were moderately cited (<400 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-293: The petitioner/beneficiary was a biochemical scientist (structural biology) and worked at a US private research hospital. She earned her Ph.D. China and published seven journal research articles. These publications were widely cited (>600 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-292: The petitioner/beneficiary was a biomedical scientist (cancer research, non-coding RNA) and worked at a US public university. He earned his Ph.D. in China and published 22 journal research articles. These publications were very widely cited (>2500 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE).

EB1A-291: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US private research hospital. He earned his Ph.D. in the United States and published nine journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-290: The petitioner/beneficiary was a chemical and materials scientist (biotechnology) and worked at a US private research institute. He earned his Ph.D. in the United States and published over ten journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-289: The petitioner/beneficiary was a biomedical scientist (cell reprogramming, genomics) and worked at a US private research institute. He earned his Ph.D. in China and published six journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-288: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US public university. He earned his Ph.D. in the United States and published over twenty journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-287: The petitioner/beneficiary was a chemical scientist (analytical chemistry) and worked at a US biopharmaceutical company. She earned her Ph.D. in the United States and published about ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-286: The petitioner/beneficiary was a biomedical scientist (eye disease) and worked at a US private university. She earned her Ph.D. in China and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved three months later (After RFE).

EB1A-285: The petitioner/beneficiary was a biomedical scientist (hypertension, gut microbiota ) and worked at a US public university. He earned his Ph.D. in the United States and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-284: The petitioner/beneficiary was a biomedical scientist (human genetics, gene mutations) and worked at a US research hospital. He earned his Ph.D. in China and published twenty journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-283: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, protein structure) and worked at a US medical school. He earned his Ph.D. in the United States and published six journal research articles. These publications were widely cited by others. The petition was filed in 2017 and approved one year later (after RFE).

EB1A-282: The petitioner/beneficiary was a biomedical scientist (neuroscience, pain research) and worked at a US private university. She earned her Ph.D. in China and published ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-281: The petitioner/beneficiary was a pharmaceutical scientist (pharmacology, population pharmacokinetics) and worked at a major pharmaceutical company. She received undergraduate education in China and earned her Ph.D. in the United States. The petitioner published 13 journal research articles. Some publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-280: The petitioner/beneficiary was a biomedical scientist (brain disease, neuroscience) and worked at a US medical school and private hospital. He received his Ph.D. in the United States and published seven journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-279: The petitioner/beneficiary was a computer scientist (bioinformatics, computational biology) and worked at a US medical school. He earned his Ph.D. in Computer Science in China and received postdoctoral training in the United States. The petitioner co-authored and published some research articles and book chapters in Chinese and English. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineering) and worked at a US public university. She received her Ph.D. in the United States and published over ten journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-277: The petitioner/beneficiary was a medical scientist (stem cell therapy) and worked at a US medical school. She received her Ph.D. in China and published eight journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-276: The petitioner/beneficiary was a biomedical scientist (insect immunology, immunology) and worked at a US medical school. She received her Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved four months later (after RFE).

EB1A-275: The petitioner/beneficiary was a biomedical scientist (autophagy) and worked at a US public university. She received her Ph.D. in the United States and published over 10 journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-274: The petitioner/beneficiary was a biological scientist (neuroscience) and worked at a US private university. He received Ph.D. in the United States and published over several journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved one week later (No RFE).

EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineering) and worked at a US public university. She received her Ph.D. in the United States and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-273: The petitioner/beneficiary was a chemical scientist (organic chemistry) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-272: The petitioner/beneficiary was a medical scientist (stem cell, biomedical engineering) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-271: The petitioner/beneficiary was a medical scientist (HCV, cell reprogramming) and worked at a US medical school. She received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-270: The petitioner/beneficiary was a medical scientist (neuroscience, neurodegenerative disease) and worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-269: The petitioner/beneficiary was a biological scientist (autophagy) and worked at a US public university. He received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (after RFE).

EB1A-268: The petitioner/beneficiary was a medical scientist (stem cells, cancer, epigenetics) and worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-267: The petitioner/beneficiary was a medical scientist (human medical genetics, RNA biology) and worked at a US medical school. He received Ph.D. in China and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-266: The petitioner/beneficiary was a chemical scientist (natural products, drug development, biomaterials) and worked at a US medical school. He received Ph.D. in Hong Kong and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-265: The petitioner/beneficiary was a mathematical scientist (computational mathematics) and worked at an Associate Professor at a US public university. He received Ph.D. in the United States and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-264: The petitioner/beneficiary was a chemical scientist (analytical chemistry, proteomics, mass spectrometry, etc.) and worked at a US private university. He received Ph.D. in China and published over 30 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-263: The petitioner/beneficiary was a biomedical scientist (obesity, diabetes, adipose tissue, stress response, nutritional science) and worked at a US medical school. He received Ph.D. in China and published about twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-262: The petitioner/beneficiary was a neuroscientist (memory and learning, sexual behavior) and worked at a US medical school. He received Ph.D. in Austria and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-261: The petitioner/beneficiary was a materials scientist (battery) and worked at a US national laboratory. He received Ph.D. in the United States and published nine research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-260: The petitioner/beneficiary was a biomedical scientist (maternal diabetes, cardiovascular disease) and worked at a US public university. She received Ph.D. in China and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-259: The petitioner/beneficiary was a biophysicist and biomedical scientist (biophysics, biomedical engineering, etc.) and worked at a US public university. He received M.S. in China and Ph.D. in the United States and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-258: The petitioner/beneficiary was a biomaterials scientist (biomedical and mechanical engineering) and worked at a US public university. He received Ph.D. in Canada and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-257: The petitioner/beneficiary was a biochemist (traditional Chinese medicine, cardiovascular disease) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-256: The petitioner/beneficiary was a biomedical scientist (developmental biology, stem cells) and worked at a US public university. She received Ph.D. in China and published seventeen research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-255: The petitioner/beneficiary was a biomedical scientist (skin disease, melanoma, prostate cancer) and worked at a US public university. He received Ph.D. in Sweden and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-254: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US public university. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-253: The petitioner/beneficiary was a biomedical scientist (RNA biology, X chromosome inactivation) and worked at a US medical school. He received Ph.D. in the United States and published eight research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-252: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. He received Ph.D. in China and published over twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-251: The petitioner/beneficiary was a biomedical scientist (genomics, bioinformatics, stem cells) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-250: The petitioner/beneficiary was a biomedical scientist and engineer (microscopy, imaging technology) and worked at a US national laboratory. He received Ph.D. in Singapore and published seventeen research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-249: The petitioner/beneficiary was a neuroscientist (monoarthritis, pain sensation) and worked at a US medical school. She received Ph.D. in China and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-248: The petitioner/beneficiary was a biochemist and molecular biologist (insect biology, biomedical sciences) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-247: The petitioner/beneficiary was a neuroscientist (pain research) and worked at a US medical school. He received Ph.D. in China and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-246: The petitioner/beneficiary was a biomedical scientist (human genetics, gene therapy) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two months later (after RFE).

EB1A-245: The petitioner/beneficiary was an environmental scientist (agricultural chemicals) and worked at a US public university. He received Ph.D. in China and published about 40 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-244: The petitioner/beneficiary was a biomedical scientist (cancer research, HBV) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. One publication was widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-243: The petitioner/beneficiary was a biomedical scientist (biomaterials, biomedical engineering) and worked at a US medical school. She received Ph.D. Japan and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-242: The petitioner/beneficiary was a biomedical scientist (drug delivery systems, pharmacology) and worked at a US Federal government agency. She received Ph.D. in the United States and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-241: The petitioner/beneficiary was a biomedical scientist (neuroscience) and worked at a US medical school. He received Ph.D. in Germany and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-240: The petitioner/beneficiary was a biomedical scientist (biomedical engineering, ultrasound) and worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-239: The petitioner/beneficiary was a plant and crop scientist (plant genetics) and worked at a US private research institute school. He received Ph.D. in China and published several research articles in English journals. Two publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-238: The petitioner/beneficiary was a chemical scientist (polymer science) and worked at a US private university. He received Ph.D. in China and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-237: The petitioner/beneficiary was a biomedical scientist (genome architecture, gene expression regulation) and worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-236: The petitioner/beneficiary was a biomedical scientist (Microbiology/stem cells) and worked at a US public university. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-235: The petitioner/beneficiary was a biomedical scientist (developmental biology/genomics) and worked at a US medical school. He received Ph.D. in Hong Kong and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-234: The petitioner/beneficiary was an atmospheric scientist (climate change) and worked at a US public University. She received Ph.D. in the United States and published over ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-233: The petitioner/beneficiary was a financial scientist (accounting/business administration) and worked at a US community college. He received Ph.D. in China and published some research articles. He also played a critical role in an international organization. One Chinese publication was moderately cited by others. The petition was filed in 2016 and approved ten months later (after RFE, denial, and appeal to AAO).

EB1A-232: The petitioner/beneficiary was a biomedical scientist (Leukemia/protein structures) and worked at a US public university. She received Ph.D. in China and published about twenty research articles. One publication was very widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-231: The petitioner/beneficiary was a biomedical scientist (neurodegenerative disease/AD/PD) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-230: The petitioner/beneficiary was a materials scientist (sensors, graphene, etc.) and worked at a US public university. He received Ph.D. in the United States and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-229: The petitioner/beneficiary was a medical scientist (cancer biomarkers) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-228: The petitioner/beneficiary was a biomedical scientist (gene transcription regulation/cancer research) and worked at a US Federal research agency. She received Ph.D. in the United States and published several research articles. Two publications were widely cited by others. The petition was filed in 2016 and approved several days later (After RFE).

EB1A-227: The petitioner/beneficiary was a biomedical scientist (neuroscience/developmental biology) and worked at a US medical school. He received Ph.D. in France and published about ten research articles. One publication was very widely cited by others. The petition was filed in 2016 and approved several months later (after RFE).

EB1A-226: The petitioner/beneficiary was a medical physicist (CT cancer diagnosis) and worked at a US public university. He received Ph.D. in the United States and published about forty journal and conference research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-225: The petitioner/beneficiary was a biomedical scientist (HIV Immunology) and worked at a US Federal research institute. He received Ph.D. in the United States and published about ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-224: The petitioner/beneficiary was a biomedical scientist (biomedical engineering) and worked at a US medical school. She received Ph.D. in the United States and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-223: The petitioner/beneficiary was a medical scientist (cancer/neurodegenerative disease) and worked at a US public university. She received Ph.D. in China and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-222: The petitioner/beneficiary was a biomedical scientist (immunology) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications was moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-221: The petitioner/beneficiary was a biological scientist (plant science/neuroscience) and worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-220: The petitioner/beneficiary was a chemist and pharmaceutical scientist (bio-detection) and worked at a US medical school. She received Ph.D. in the United States and published over ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-219: The petitioner/beneficiary was a medical scientist (cardiovascular diseases) and worked at a US medical school. She received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved in 2016 (After RFE).

EB1A-218: The petitioner/beneficiary was a chemist and materials scientist (energy storage) and worked at a US national laboratory. She received Ph.D. in China and published over twenty research articles. These publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-217: The petitioner/beneficiary was a medical scientist (tissue engineering and organ transplantation) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-216: The petitioner/beneficiary was a medical scientist (eye disease) and worked at a US public university. He received Ph.D. in Germany and published about twenty research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-215: The petitioner/beneficiary was a medical scientist (pharmacology) and worked at a US public medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-214: The petitioner/beneficiary was a space scientist (solar physics) and worked at a US public university. She received Ph.D. in the United States and published about ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-213: The petitioner/beneficiary was a neuroscientist (channels, neuron identification) and worked at a US private research institute. He received Ph.D. in the United States and published over ten research articles. These publications were widely cited by others (>1200 times). The petition was filed in 2016 and approved several days later (No RFE).

EB1A-212: The petitioner/beneficiary was a biomedical scientist (breast cancer) and worked at a US private medical school. She received Ph.D. in the United States and published four research articles. These publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-211: The petitioner/beneficiary was a biomedical scientist (immunology) and worked at a US public university. He received Ph.D. in the United States and published about ten research articles. These publications were widely cited by others (>1800 times). The petition was filed in 2016 and approved several days later (No RFE).

EB1A-210: The petitioner/beneficiary was an animal scientist (poultry science) and worked at a US public university. She received Ph.D. in the United States and published about fifteen research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-209: The petitioner/beneficiary was a medical scientist (Radiology; medial imaging) and worked at a US medical school. He received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-208: The petitioner/beneficiary was a biomedical scientist (immunology; blood disease) and worked at a US university. He received Ph.D. in the United States and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-207: The petitioner/beneficiary was a biomedical scientist (histone methylation; epigenetics) and worked at a US medical school. He received Ph.D. in China and published five research articles. Two publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-206: The petitioner/beneficiary was a medical geneticist (human genetic diseases) and worked at a US medical school. He received Ph.D. in the United States and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-205: The petitioner/beneficiary was a biomedical scientist (liver disease; pain research) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-204: The petitioner/beneficiary was a medical scientist (cancer research) and was an M.S. graduate student at a US university. She received M.D. and Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-203: The petitioner/beneficiary was a biomedical scientist (cancer research; stem cells) and worked at a US medical school. He received Ph.D. in the United States and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-202: The petitioner/beneficiary was a biomedical scientist (immunology) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. Some publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-201: The petitioner/beneficiary was a biomedical scientist (Endocrinology; developmental biology) and worked at a US medical school. He received Ph.D. in China and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-200: The petitioner/beneficiary was a chemist (reduction of carbon dioxide) and worked at a US private university. He received Ph.D. in the United States and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-199: The petitioner/beneficiary was a neuroscientist (neuroscience; methodology) and worked at a US private medical school. He received Ph.D. in the United States and published four research articles. One publication was widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-198: The petitioner/beneficiary was a biological scientist (cell migration; biological clock) and worked at a US public medical school. He received Ph.D. in China and published less than ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved three months later (after RFE).

EB1A-197: The petitioner/beneficiary was a chemist (reduction of water; hydrogen generation) and worked at a US public university. He received Ph.D. in India and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-196: The petitioner/beneficiary was a biochemist and neuroscientist (proteomics and neuroscience) and worked at a US public university. She received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-195: The petitioner/beneficiary was a physicist and materials scientist (oxide electronics) and worked at a US public university. He received Ph.D. in Singapore and published over thirty research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-194: The petitioner/beneficiary was a language teacher (teaching Chinese as second language) and worked at a US public university. She received M.A. in China and has more then ten-year teaching experience. The petition was filed in 2015 and approved in 2016 (No RFE).

EB1A-193: The petitioner/beneficiary was a medical scientist (signal transduction, heart disease) and worked at a US medical school. He received Ph.D. in the United States and published over 10 research articles. These publications were modestly cited by others. The petition was filed in 2015 and approved in 2016 (After RFE).

EB1A-192: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).

EB1A-191: The petitioner/beneficiary was a chemical scientist (intermediate compounds, catalysts) and worked at a US national laboratory. He received Ph.D. in China and published about 30 research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved one week later (No RFE).

EB1A-190: The petitioner/beneficiary was a biomedical scientist (ion channels, drug discovery) and worked at a US medical school. He received Ph.D. in the United States and published about seven research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved one week later (No RFE).

EB1A-189: The petitioner/beneficiary was a biomedical scientist (developmental biology, cancer research) and worked at a US medical school. He received Ph.D. in China and published about 30 Chinese and English research articles. These publications were moderately cited by others. The petition was filed in December 2015 and approved in January 2016 (No RFE).

EB1A-188: The petitioner/beneficiary was a biomedical scientist (cancer research, cell division) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved one week later (No RFE).

EB1A-187: The petitioner/beneficiary was a biomedical scientist (neurodegenerative diseases) and worked at a US medical school. He received Ph.D. in China and published five research articles. Four publications were widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-186: The petitioner/beneficiary was a biomedical scientist (autophagy/DNA damage repair) and worked at a US research institute. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-185: The petitioner/beneficiary was a biomedical scientist (bioinformatics/cancer) and worked at a US major pharmaceutical company. He received Ph.D. in the United States and published over ten research and review articles. These publications were modestly cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-184: The petitioner/beneficiary was a biomedical scientist (biochemistry/protein modification) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. A few publications were substantially cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-183: The petitioner/beneficiary was a biomedical scientist (protein methylation/demethylation) and worked at a US medical school. He received Ph.D. in China and published about ten research and review articles. These publications were moderately cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-182: The petitioner/beneficiary was a biomedical scientist (transcriptome, RNA biology, drug discovery) and worked at a US medical school. He received Ph.D. in the United States and published about ten research and review articles. Two publications were widely cited by others. The petition was filed in 2015 and approved one month later (No RFE).

EB1A-181: The petitioner/beneficiary was a biomedical scientist (kinases and human diseases) and worked at a US medical research institute. He received Ph.D. in the United States and published eight research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-180: The petitioner/beneficiary was a medical scientist (developmental biology/clinical diagnosis) and worked at a US biotechnology company. She received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved ten days later (No RFE).

EB1A-179: The petitioner/beneficiary was a medical scientist (autophagy) and worked at a US medical school. He received Ph.D. in the United States and published about ten research articles. Some publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-178: The petitioner/beneficiary was an electrical engineer and scientist (power electronics) and worked at a US public university. He received Ph.D. in India and published over 30 journal and conference articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-177: The petitioner/beneficiary was a chemical scientist (NMR) and worked at a US public university. He received Ph.D. in India and published about twenty research articles. One publication was widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-176: The petitioner/beneficiary was a chemical scientist (computational chemistry) and worked at a US public university. He received Ph.D. in China and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2014 and approved in 2015 (No RFE).

EB1A-175: The petitioner/beneficiary was a chemical scientist (graphene-based new materials) and worked at a US public university. He received Ph.D. in China and published over 30 research articles. These publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-174: The petitioner/beneficiary was a chemical scientist (organic solar cell materials) and worked at a US private university. She received Ph.D. in China and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-173: The petitioner/beneficiary was a chemical scientist (visible light driven chemical reactions) and worked at a US private university. She received Ph.D. in the United States and published several research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved two weeks later (No RFE).

EB1A-172: The petitioner/beneficiary was a biomedical scientist (DNA methylation/demethylation, stem cells, neural development, heart disease) and worked at a US medical school. He received Ph.D. in the United States and published about 30 research and review articles. These publications were very widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-171: The petitioner/beneficiary was a biomedical scientist (DNA methylation/demethylation, stem cells) and worked at a US medical school. He received Ph.D. in China and published about 20 research articles. These publications were very widely cited by others. The petition was filed in 2015 and approved two days later (No RFE).

EB1A-170: The petitioner/beneficiary was a chemical scientist (photomechanical chemistry) and worked at a US public university. She received Ph.D. in the United States and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved six weeks later (after RFE).

EB1A-169: The petitioner/beneficiary was an environmental scientist (detection of trace antibiotics in waters) and worked at a US public university. She received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-168: The petitioner/beneficiary was a medical scientist (cancer research, DNA modification, stem cells) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2014 and approved in 2015 (No RFE).

EB1A-167: The petitioner/beneficiary was a biochemical scientist (structural biology) and worked at a US medical school. She received Ph.D. in the United States and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-166: The petitioner/beneficiary was a medical scientist (cancer research and transcription regulation) and worked at a US medical school. He received Ph.D. in Canada and published about 30 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-165: The petitioner/beneficiary was a medical scientist (alternative splicing, muscle development) and worked at a US medical school. He received Ph.D. in the United States and published about 10 research articles. Some publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-164: The petitioner/beneficiary was a medical scientist (cancer research, kidney disease) and worked at a US medical school. She received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2014 and approved in 2015 (No RFE).

EB1A-163: The petitioner/beneficiary was a materials scientist (solar energy materials, nanomaterials) and worked at a US public university. He received Ph.D. in the United States and published about 20 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-162: The petitioner/beneficiary was a chemical scientist (nanomaterials, water treatment) and worked at a US private university. He received Ph.D. in China and published over 20 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-161: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US private university. She received Ph.D. in the United States and published about 10 research articles. These publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-160: The petitioner/beneficiary was a medical scientist (diabetes) and worked at a US public medical school. He received Ph.D. in Japan and published about several research articles. One paper was widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-159: The petitioner/beneficiary was a biological scientist (neuroscience) and worked at a US public university. She received Ph.D. in the United States and published about several research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (after RFE).

EB1A-158: The petitioner/beneficiary was a biophysical/biomedical scientist (biophysics) and worked at a US public university. He received Ph.D. in the United States and published about 10 research articles. Some publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-157: The petitioner/beneficiary was a medical scientist (blood disease) and worked at a US public medical school. He received Ph.D. in China and published about 20 research articles. One paper was widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-156: The petitioner/beneficiary was a medical scientist (Signal transduction, brain cancer ) and worked at a US public university. He received Ph.D. in China and published about several research articles. These publications were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-155: The petitioner/beneficiary was a medical scientist (Immunology) and worked at a US private university. He received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-154: The petitioner/beneficiary was a medical scientist (biomedical enginering) and worked at a US public university. He received Ph.D. in the United States and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved 10 days later (No RFE).

EB1A-153: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US medical school. He received Ph.D. in China and published about over ten research articles. Some papers were widely cited by others. The petition was filed in 2015 and approved two weeks later (No RFE).

EB1A-152: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US medical school. He received Ph.D. in the United States and published about 20 research articles. Some papers were widely cited by others. The petition was filed in 2015 and approved three months later (After RFE).

EB1A-151: The petitioner/beneficiary was a medical scientist (Neuroscience) and worked at a US medical school. She received Ph.D. in the United States and published about 10 research articles. These papers were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-150: The petitioner/beneficiary was a chemical and materials scientist (nanomaterials) and worked at a US national laboratory. He received Ph.D. in the United States and published about 20 research articles. Some papers were widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-149: The petitioner/beneficiary was a medical scientist (Immunology) and worked at a US medical school. He received Ph.D. in China and published about 20 research articles. Some papers were widely cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-148: The petitioner/beneficiary was a medical scientist (heart development) and worked at a US private research institute. He received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).

EB1A-147: The petitioner/beneficiary was a medical scientist (Parkinson's disease, Pharmacology) and worked at a US private university. She received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved one month later (No RFE).

EB1A-146: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US medical school. He received Ph.D. in the United States and published over 10 research articles. Some papers were widely cited by others. The petition was filed in 2014 and approved in 2015 (after RFE).

EB1A-145: The petitioner/beneficiary was a chemical scientist (photochemistry) and worked at a US private university. She received Ph.D. in India and published about 20 research articles. Two papers were widely cited by others. The petition was filed in 2015 and approved ten days later (No RFE).

EB1A-144: The petitioner/beneficiary was a medical scientist (cancer research) and worked at a US public university. She received Ph.D. in the United States and published about 10 research articles. These papers were moderately cited by others. The petition was filed in 2015 and approved ten days later (No RFE).

EB1A-143: The petitioner/beneficiary was a chemical scientist (analytical chemistry and proteomics) and worked at a US private university. He received Ph.D. in China and published about 50 research articles. Some papers were widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-142: The petitioner/beneficiary was a biomedical scientist (bone and cancer research) and worked at a US private research institute. He received Ph.D. in the United States and published five original research articles. One paper was widely cited by others. The petition was filed in 2015 and approved two days later (No RFE).

EB1A-141: The petitioner/beneficiary was a medical scientist (pain research) and worked at a US medical school. He received Ph.D. in China and published about twenty original research articles. These publications were moderately widely cited by others. The petition was filed in 2014 and approved six months later (No RFE).

EB1A-140: The petitioner/beneficiary was a chemical scientist (foldamers) and worked at a US public university. He received Ph.D. in India and published about twenty original research articles. One paper was widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).

EB1A-139: The petitioner/beneficiary was a chemical scientist (NMR technology) and worked at a US private research institute. He received Ph.D. in the United States and published about ten original research articles. One paper was widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-138: The petitioner/beneficiary was a biomedical scientist (RNA biology) and worked at a US medical school. He received Ph.D. in the United States and published about ten original research articles. Some papers were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-137: The petitioner/beneficiary was a medical scientist (NF-kB, cancer research) and worked at a US public university. He received Ph.D. in China and published over ten original research articles. These papers were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-136: The petitioner/beneficiary was a medical scientist (HDAC, cancer research) and worked at a US public medical school. He received Ph.D. in China and published about ten original research articles. These papers were modestly cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-135: The petitioner/beneficiary was an environmental scientist (PFCs, BPA etc.) and worked at a US public university. He received Ph.D. in China and published over sixty original research articles. Some papers were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-134: The petitioner/beneficiary was a biomedical scientist (DNA/RNA modification) and worked at a US private research institute. He received Ph.D. in China and published three original research articles. One paper was widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-133: The petitioner/beneficiary was a medical scientist (stem cell research) and worked at a US medical school. She received Ph.D. in China and published about ten peer-reviewed research articles. These publications were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-132: The petitioner/beneficiary was a neuroscientist (memory storage) and worked at a US medical school. He received Ph.D. in the United States and published several peer-reviewed research articles in prestigious journals. These publications were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-131: The petitioner/beneficiary was a chemical and materials scientist (batteries) and worked at a US national laboratory. He received Ph.D. in China and published over twenty peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved two weeks later (No RFE).

EB1A-130: The petitioner/beneficiary was a biomedical scientist (developmental biology) and worked at a US private research institute. He received Ph.D. in China and published about six peer-reviewed research articles. These publications were moderately cited. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-129: The petitioner/beneficiary was a chemical scientist (NMR technology) and worked at a US public university. He received Ph.D. in Canada and published about thirty peer-reviewed research articles. These publications were moderately cited. The petition was filed in 2014 and approved six months later (No RFE).

EB1A-128: The petitioner/beneficiary was a plant scientist (plant defense system) and worked at a US public school. He received Ph.D. in the United States and published over ten peer-reviewed research and review articles. These publications were moderately cited. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-127: The petitioner/beneficiary was a biomedical scientist (hypertension, etc.) and worked at a US Federal research institute. He received Ph.D. in China and published about twenty peer-reviewed research articles. These publications were moderately cited. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-126: The petitioner/beneficiary was a biomedical scientist (developmental biology) and worked at a US medical school. She received Ph.D. in the United States and published about ten peer-reviewed research articles. these publications were moderately cited. The petition was filed in 2014 and approved several months later (No RFE).

EB1A-125: The petitioner/beneficiary was a physical scientist (ultrasound and medical imaging) and worked at a US public university. He received Ph.D. in the United States and published over ten peer-reviewed research articles. these publications were moderately cited. The petition was filed in 2014 and approved nine months later (after RFE).

EB1A-124: The petitioner/beneficiary was a biomedical scientist (Alzheimer's disease) and worked at a US medical school. He received Ph.D. in the United States and published over ten peer-reviewed research articles. these publications were moderately cited. The petition was filed in 2014 and approved several days later (no RFE).

EB1A-123: The petitioner/beneficiary was a chemical scientist (inorganic chemistry) and worked at a US public university. He Ph.D. in China and published over eight peer-reviewed research articles. One article was widely cited. The petition was filed in 2014 and approved several days later (no RFE).

EB1A-122: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. He received M.S. and Ph.D. in the United States and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved about six months later (no RFE).

EB1A-121: The petitioner/beneficiary was a biomedical scientist (cancer research, protein modification) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved about three months later (no RFE).

EB1A-120: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved about ten days later (no RFE).

EB1A-119: The petitioner/beneficiary was a biomedical scientist (reproductive biology, metabolism) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved about several days later (no RFE).

EB1A-118: The petitioner/beneficiary was a biochemist (plant science) and worked at a US public university. He received PhD in the United States and published over ten peer-reviewed research articles. These publications were modestly cited by others. The petition was filed in 2014 and approved about three months later (after RFE).

EB1A-117: The petitioner/beneficiary was a biomedical scientist (neuroscience) and worked at a US medical school. He received PhD in China and published about twenty peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved about ten days later (no RFE).

EB1A-116: The petitioner/beneficiary was a biochemical scientist (organic synthesis and drug development) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved one week later (no RFE).

EB1A-115: The petitioner/beneficiary was a chemical scientist (chemical and biochemical engineering) and worked at a US public university. He received PhD in the United States and published about ten peer-reviewed research and review articles. These publications were moderately cited by others. The petition was filed in 2013 and approved in 2014 (no RFE; pending ten months).

EB1A-114: The petitioner/beneficiary was an environmental scientist (teratogens and PPCPs) and worked at a US public university. She received PhD in China and published about ten peer-reviewed research articles. These publications were moderately cited by others. The petition was filed in 2014 and approved one week later (no RFE).

EB1A-113: The petitioner/beneficiary was a chemical scientist (new materials for drug delivery) and worked at a US public university. He received M.S. in India and PhD in the United States and published over ten peer-reviewed research articles. Some publications were widely cited by others. The petition was filed in 2014 and approved two weeks later (no RFE).

EB1A-112: The petitioner/beneficiary was a medical scientist (MER-coV) and worked at a US medical school. She received PhD in China and published over ten peer-reviewed research papers. These publications were moderately cited by others. The petition was filed in 2014 and approved two months later (after NOID).

EB1A-111: The petitioner/beneficiary was a biomedical scientist (neuroscience, Parkinson's disease) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research papers. These publications were moderately cited by others. The petition was filed in 2013 and approved in 2014 (No RFE).

EB1A-110: The petitioner/beneficiary was a biomedical scientist (Toxicology and dermatology) and worked at a US Federal research agency. She received PhD in China and published about thirty peer-reviewed research papers. These publications were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-109: The petitioner/beneficiary was a chemical scientist (fluorine chemistry) and worked at a US public university. He received PhD in China and published over ten peer-reviewed research papers. These publications were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-108: The petitioner/beneficiary was a biomedical scientist (metabolism) and worked at a US medical school. Shee received PhD in China and published about ten peer-reviewed research papers. These publications were moderately cited by others. The petition was filed in 2013 and approved in 2014 (No RFE).

EB1A-107: The petitioner/beneficiary was a biomedical scientist (signal transduction, metabolism) and worked at a US independent research institute. He received PhD in China and published four peer-reviewed research papers. Two papers were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-106: The petitioner/beneficiary was a medical scientist (immunology) and worked at a US medical school and hospital. He received PhD in Japan and published over ten peer-reviewed research papers. Some papers were widely cited by others. The petition was filed in 2014 and approved one month later (After RFE).

EB1A-105: The petitioner/beneficiary was a biomedical scientist (signal transduction and cancer research) and worked at a US Federal agency. She received PhD in Germany and published about ten peer-reviewed research papers. Some papers were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-104: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. He received PhD in China and published about ten peer-reviewed research papers. These papers were modestly cited by others. The petition was filed in 2014 and approved one month later (No RFE).

EB1A-103: The petitioner/beneficiary was a biomedical scientist (reproduction biology and cancer research) and worked at a US medical school. He received PhD in China and published about ten peer-reviewed research papers. These papers were modestly cited by others. The petition was filed in 2014 and approved several days later (No RFE).

EB1A-102: The petitioner/beneficiary was a medical scientist (multiple sclerosis research) and worked at a US medical school. She received PhD in China and published about ten peer-reviewed research papers. These papers were modestly cited by others. The petition was filed in 2013 and approved in 2014 (After RFE).

EB1A-101: The petitioner/beneficiary was a bioinformatics scientist (genomics and cancer research) and worked at a US medical school. He received PhD in China and published over ten peer-reviewed research papers. A few papers were substantially cited by others. The petition was filed in 2014 and approved one week later (No RFE).

EB1A-100: The petitioner/beneficiary was a medical scientist (diabetes and cancer research) and worked at a US medical school. She received PhD in the United States and published about ten peer-reviewed research and review papers. Some papers were moderately cited by others. The petition was filed in 2013 and approved in 2014 (No RFE).

EB1A-99: The petitioner/beneficiary was a chemical scientist (peptide and protein science) and worked at a US public university. He received PhD in India and published over ten peer-reviewed research articles. These papers were moderately cited. The petition was filed in 2013 and approved in 2014 (after RFE).

EB1A-98: The petitioner/beneficiary was a medical scientist (heart regeneration and disease) and worked at a US medical school. He received PhD in China and published about ten peer-reviewed papers. One paper was widely cited and one paper was reported numerous times by news media. The petition was filed in 2014 and approved several days later ( No RFE).

EB1A-97: The petitioner/beneficiary was a biomedical scientist (heart disease and LAM) and worked at a US medical school. She received PhD in the United States and published five peer-reviewed papers. These papers were cited about 100 times. The petition was filed in 2013 and approved in 2014 (after RFE).

EB1A-96: The petitioner/beneficiary was a chemical scientist (NO and CO reduction) and worked at a US public university. He received PhD in China and published over twenty peer-reviewed papers. These papers were moderately cited by others. The petition was filed in 2013 and approved in 2014 (after RFE).

EB1A-95: The petitioner/beneficiary was a biomedical scientist (RNA biology) and worked at a US pharmaceutical company. She received PhD in the United State and published about ten peer-reviewed papers. Some papers were widely cited by others. The petition was filed in 2014 and approved several days later (no RFE).

EB1A-94: The petitioner/beneficiary was a biomedical scientist (neuroscience) and worked at a US medical school. He received PhD in China and published over thirty peer-reviewed papers as the lead or corresponding author. Some papers appeared in the top scientific journals. The petitioner's work was cited over 2000 times. The petition was filed in 2013 and approved in 2014 (no RFE).

EB1A-93: The petitioner/beneficiary was a petroleum engineer (modeling and simulation for oil production) and worked at a US energy research institution. He received PhD in the United States and published some peer-reviewed journal and conference papers. He has also played a critical role in organizations with distinguished reputation. The petition was filed in 2013 and approved in 2014 (after RFE).

EB1A-92: The petitioner/beneficiary was a computer scientist (computer graphics, simulation, animation) and worked at a US entertainment studio. She received PhD in the United States and published three journal papers and one conference paper. The conference paper was widely cited and used in the entertainment industry. The petition was filed in 2014 and approved in several days (no RFE).

EB1A-91: The petitioner/beneficiary was a materials scientist (advanced materials and nanoscience) and worked at a US university. He received PhD in the United States and published about forty journal papers. A few papers were widely cited by others. The petition was filed in 2013 and approved in 2014 (no RFE).

EB1A-90: The petitioner/beneficiary was a biomedical scientist (diabetes and obesity research) and worked at a US medical. He received PhD in the United States and published about ten journal papers. A few papers were moderately cited by others. The petition was filed in 2013 and approved in 2014 (no RFE).

EB1A-89: The petitioner/beneficiary was a biomedical scientist (cell biology) and worked at a US university. He received PhD in China and published about ten journal papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-88: The petitioner/beneficiary was a materials scientist (metal and alloy science) and worked at a US university. He received PhD in China and published about ten journal papers. Some papers were widely cited by others. The petition was filed in 2013 and approved one month later (no RFE).

EB1A-87: The petitioner/beneficiary was a medical scientist (cancer research and new drug development) and worked at a leading US biopharmaceutical company. He received PhD in the United States and published over ten journal papers. Some papers were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-86: The petitioner/beneficiary was a medical imaging scientist (DTI imaging) and worked at a US university. He received PhD in Hong Kong and published over ten journal papers. Some papers were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-85: The petitioner/beneficiary was a computer scientist (Wireless network) and worked at a top US high-tech company. He received PhD in the United States and published over ten conference papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-84: The petitioner/beneficiary was a biomaterials scientist (resilin) and worked at a US university. He received PhD in China and published over ten journal papers. These papers were cited over 100 times in total. The petition was filed in 2013 and approved several months later (after RFE).

EB1A-83: The petitioner/beneficiary was a materials scientist (new battery technology) and worked at a US national laboratory. He received PhD in China and published about 20 journal papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-82: The petitioner/beneficiary was a biomedical scientist (neurodegenerative disease model) and worked at a US medical school. She received PhD in the United States and published two original research articles and one review paper. One paper was widely cited by others. The petition was filed in 2013 and approved several months later (after RFE).

EB1A-81: The petitioner/beneficiary was a computer scientist (machine learning, massive data search) and worked at a top US technology company. He received PhD in the United States and published about 50 journal and conference papers. Some papers were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-80: The petitioner/beneficiary was a medical scientist (bioinformatics and cancer research) and worked at a US medical school. He received PhD in China and published about 30 research papers. Some papers were widely cited by others. The petition was filed in 2013 and approved nine months later (no RFE).

EB1A-79: The petitioner/beneficiary was a medical scientist (medical genetics, DTI imaging) and worked at a US medical school. He received PhD in Europe and published over ten research papers. These papers were widely cited by others. The petition was filed in 2013 and approved two days later (no RFE).

EB1A-78: The petitioner/beneficiary was a biomedical scientist (gene transcription) and worked at a US university. She received PhD in the United States and published about ten research papers. These papers were moderately cited by others. The petition was filed in 2013 and approved two months later (after Notice of Intent to Deny).

EB1A-77: The petitioner/beneficiary was a biochemical scientist (NMR structural biology) and worked at a US Federal agency. He received PhD in the United States and published nine research papers. These papers were moderately cited by others. The petition was filed in 2013 and approved two months later (no RFE).

EB1A-76: The petitioner/beneficiary was a bioinformatics scientist and worked at a US public university. He received PhD in the United States and published over ten research papers. Some papers were widely cited. The petitioner/beneficiary also developed bioinformatics tools that were widely used by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-75: The petitioner/beneficiary was a biomedical scientist (immunology) and worked at a US medical school. He received PhD in China and published about twenty research papers. Some papers were substantially cited by others. The petition was filed in 2013 and approved nine months later (no RFE).

EB1A-74: The petitioner/beneficiary was a biomedical scientist (autophagy and cell death) and worked at a US medical school. He received PhD in the United States and published over ten research papers. Some papers were very widely cited by others. The petition was filed in 2013 and approved one week later (no RFE).

EB1A-73: The petitioner/beneficiary was a biomedical scientist (model of heart disease and regeneration) and worked at a US university. He received PhD in the United States and published several research papers. One paper was widely reported and highlighted. The petition was filed in 2013 and approved two months later (after RFE).

EB1A-72: The petitioner/beneficiary was a biomedical scientist (cancer and virus research) and worked at a US university. She received PhD in the United States and published four research papers. These publications were moderately cited by others. The petition was filed in 2013 and approved three months later (after notice of intent to deny, or NOID).

EB1A-71: The petitioner/beneficiary was a biochemical scientist (drug discovery for brain cancer treatment) and worked at a US university. He received PhD in India and published over ten research papers. Some papers were substantially cited by others. The petition was filed in 2013 and approved two days later (no RFE).

EB1A-70: The petitioner/beneficiary was a chemical scientist (quantum dots) and worked at a US university. He received PhD in the United States and published over ten research papers. Some papers were moderately cited by others. The petition was filed in 2013 and approved two days later (no RFE).

EB1A-69: The petitioner/beneficiary was a medical scientist (Alzheimer's disease) and worked at a US medical school. He received PhD in China and published about 20 research papers. Half of the publications are in Chinese. These publications were moderately cited by others. The petition was filed in 2013 and approved six months later (with RFE).

EB1A-68: The petitioner/beneficiary was a materials scientist (new battery technology) and worked at a US university. He received PhD in China and published about 20 research papers. Some papers were substantially cited by others. The petition was filed in 2013 and approved two days later (no RFE).

EB1A-67: The petitioner/beneficiary was a biomedical scientist (neuroscience) and worked at a US medical schgool. He received MD in China and PhD in the United States and published 40 research papers, most of them in Chinese. Some papers were substantially cited by others. The petition was filed in 2013 and approved two days later (no RFE).

EB1A-66: The petitioner/beneficiary was a biomedical scientist (Alzheimer's disease) and worked at a US medical school. He received PhD in the United States and published about ten research papers. These papers were substantially cited by others. The petition was filed in 2013 and approved one month later (no RFE).

EB1A-65: The petitioner/beneficiary was a biomedical scientist (protein modification) and worked at a US research institute. He received PhD in China and published three research papers. These papers were widely cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-64: The petitioner/beneficiary was a chemical scientist (inorganic chemistry) and worked at a US national laboratory. He received PhD in the United States and published fifteen research articles. These papers were widely cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-63: The petitioner/beneficiary was a medical scientist (immunology and cardiovascular biology) and worked at a US medical school. He received PhD in China and published six papers in English journals and over ten articles in Chinese journals. These papers were modestly cited by others. The petition was filed in 2013 and approved eight months later (no RFE).

EB1A-62: The petitioner/beneficiary was a computer scientist (computer vision, neuroimaging, DTI) and worked at a US public university. He received PhD in the United States and published nearly forty journal and conference papers. These papers were modestly cited by others. The petition was filed in 2013 and approved ten day later (no RFE).

EB1A-61: The petitioner/beneficiary was a biochemical scientist (protein structure and function) and worked at a US public university. He received PhD in another country and published about ten research papers. These publications were moderately cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-60: The petitioner/beneficiary was a medical scientist (neuroscience, toxicology) and worked at a US medical school. He received PhD in an foreign country and published nearly twenty research papers. These papers were moderately cited by others. The petition was filed in 2012 and approved in 2013 (no RFE).

EB1A-59: The petitioner/beneficiary was a medical scientist (bioinformatics) and worked at a US medical school. She received PhD in the United States and published nearly twenty research papers. A few papers were widely cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-58: The petitioner/beneficiary was a medical scientist (virology and cancer research) and worked at a US medical school. He received PhD in the United States and published about ten research papers. These papers were moderately cited by others. The petition was filed in 2013 and approved three months later (no RFE).

EB1A-57: The petitioner/beneficiary was a medical scientist (development and bone disease) and worked at a US medical school. He received PhD in another country and published about twenty research and review  papers. These publications were moderately cited by others. The petition was filed in 2013 and approved two months later (RFE).

EB1A-56: The petitioner/beneficiary was a medical scientist (immunology) and worked at a US medical school. She received PhD in the United States and published about ten research and review  papers. Some papers were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-55: The petitioner/beneficiary was a medical scientist (medical genetics) and worked at a US medical school. He received PhD in the United States and published over ten research papers. These publications were widely cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-54: The petitioner/beneficiary was a biochemical and biomedical scientist (G-Quadruplexes, cancer) and worked at a US medical school. He received PhD in the United States and published about six research and review  papers. One research paper and one review paper were widely cited by others. The petition was filed in 2013 and approved one month later (RFE).

EB1A-53: The petitioner/beneficiary was a structural biologist (dengue virus proteins) and worked at a US medical school. He received PhD in another country and published about ten journal papers. These papers were widely cited by others. The petition was filed in 2013 and approved several days later (No RFE).

EB1A-52: The petitioner/beneficiary was a biomedical scientist (structural biology and neuroscience) and worked at a US medical school. She received PhD in another country and published about ten journal papers. These papers were modestly cited by others. The petition was filed in 2013 and approved several days later (No RFE).

EB1A-51: The petitioner/beneficiary was a reliability engineer and worked at a US manufacturing company. He received PhD in the United States and published over ten journal and conference papers. Most of the papers were not cited by others and the total citations for his English publications were between 20 to 30. The petitioner also published a paper in a foreign language which was cited  about 20 times. The petition was filed in 2013 and approved two months later (with RFE).

EB1A-50: The petitioner/beneficiary was an atmospheric scientist (climate change modeling) and worked at a US national lab. She received PhD in the United States and published about 20 journal papers. Some papers were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-49: The petitioner/beneficiary was a medical scientist and worked at a US medical school. He received PhD in another country and published about 20 journal papers. These papers were widely cited by others. The petition was filed in 2013 and approved one day later (no RFE).

EB1A-48: The petitioner/beneficiary was a medical scientist and worked at a US medical school. He received PhD in another country and published about 30 journal papers in national and international journals. Some papers were substantially cited by others. The petition was filed in 2012 and approved in 2013 (no RFE).

EB1A-47: The petitioner/beneficiary was a microbiology scientist and worked at a US public university. She received PhD in another country and published about 10 journal papers. One paper was widely cited by others. The petition was filed in 2013 and approved one week later (no RFE).

EB1A-46: The petitioner/beneficiary was a biomedical scientist and worked at a US medical school. He received PhD in the United States and published over 10 journal papers. These publications were widely cited . The petition was filed in 2013 and approved several days later (no RFE).

EB1A-45: The petitioner/beneficiary was a biological scientist and worked at a US Federal agency. He received PhD in another country and published about 10 journal papers. These publications were cited about 100 times in total. The petition was filed in 2013 and approved two months later (RFE).

EB1A-44: The petitioner/beneficiary was a medical scientist and worked at a US medical school. He received PhD in the United States and published about 10 journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-43: The petitioner/beneficiary was a chemical and biochemical scientist and worked at a US medical school. He received PhD in the United States and published about 20 journal papers. These publications were widely cited by others. The petition was filed in 2013 and approved several days later (no RFE).

EB1A-42: The petitioner/beneficiary was a chemical scientist and worked at a US medical school. He received PhD in the United States and published about 10 journal papers. These publications were cited about 50 times. Part of the petitioner's work was commercialized by a company. The petition was filed in 2012 and approved two months later (no RFE).

EB1A-41: The petitioner/beneficiary was a medical scientist (cancer research, protein modification, etc.) and worked at a US medical school. She received PhD in the United States and published 5 journal papers. Two publications were widely cited by others. The petition was filed in 2012 and approved several days later.

EB1A-40: The petitioner/beneficiary was an environmental scientist and worked at a US university and Federal agency. He received PhD in a foreign country and published about 40 journal papers. Several publications were widely cited by others. The petition was filed in 2012 and approved several days later.

EB1A-39: The petitioner/beneficiary was a medical scientist (biophysics) and worked at a US medical school. He received PhD in the United States and published over ten journal papers. These publications were widely cited by others. The petition was filed in 2012 and approved several days later.

EB1A-38: The petitioner/beneficiary was a medical scientist (cancer biology) and worked at a US medical school. She received PhD in a foreign country and published several journal papers. These publications were cited about 130 times. The petition was filed in 2012 and approved several days later.

EB1A-37: The petitioner/beneficiary was a medical scientist (structural biology) and worked at a US Federal research institute. He received PhD in a foreign country and published several journal papers. These publications were cited about 100 times. The petition was filed in 2012 and approved several days later.

EB1A-36: The petitioner/beneficiary was a medical scientist (reproductive science) and worked at a US medical. He received PhD in the United States and published about 30 journal papers. These publications were widely cited by others. The petition was filed in 2012 and approved several days later.

EB1A-35: The petitioner/beneficiary was a mathematician (applied mathematics) and worked at a US national laboratory. She received PhD degree in the United States and published over ten journal papers. These publications were substantially cited by others. The petition was filed in 2012 and approved several days later. No RFE.

EB1A-34: The petitioner/beneficiary was a medical scientist (structural biology) and worked at a US medical school. He received PhD degree in the United States and published about ten journal papers. These publications were substantially cited by others. The petition was filed in 2012 and approved two months later. No RFE.

EB1A-33: The petitioner/beneficiary was a research scientist (information theory and communications engineering) and worked for a US company. He received PhD degree in the United States and published over ten journal and conference papers. These publications were substantially cited by others. The petition was filed in 2012 and approved several days later.

EB1A-32: The petitioner/beneficiary was an electrical engineer (wireless network communications) and worked for a major US high-tech company. He received PhD in the United States and published over ten research articles. These publications were modestly cited by others. The petition was filed in 2011 and approved in 2012.

EB1A-31: The petitioner/beneficiary was a research scientist with specialties in natural language recognition. He received his PhD degree in a foreign country and published about thirty research articles. These publications were modestly cited. The petition was filed in 2012 and approved two months later.

EB1A-30: The petitioner/beneficiary was an inorganic chemist and worked as a research scientist at a US national laboratory. He received PhD in the United States and published about twenty research articles. The petition was filed in 2012 and approved several days later.

EB1A-29: The petitioner/beneficiary was a theoretical chemist and worked as a research scientist at a US national laboratory. She received PhD in the United States and published over twenty research articles. The petition was filed in 2012 and approved several days later.

EB1A-28: The petitioner/beneficiary was a bioinformatical scientist. He received PhD in the United States and published over ten research articles. His work was cited over 1000 times in total. The petition was filed  in 2012 and approved one month later.

EB1A-27: The petitioner/beneficiary was an environmental scientist and worked as a research scientist at a US university. He received PhD in the United States and published five research articles. His work was cited around 100 times in total. The petition was filed  in 2012 and approved one and half months later.

EB1A-26: The petitioner/beneficiary was a leading electrical scientist and worked as a tenure-track Assistant Professor at a famous US university. He also earned PhD at a US and world's top school. The petition was filed  in 2012 and approved several days later.

EB1A-25: The petitioner/beneficiary was a chemical scientist. He earned PhD in an foreign country and worked as a Postdoctoral scholar at a US university. The petition was filed in July, 2011 and approved in 2012.

EB1A-24: The petitioner/beneficiary was a medical scientist at a US medical school. When the petition was filed, he published about 20 research papers. These publications were widely cited by others. Some of these publications were reported and highlighted in scientific news media. The petitioner reviewed about 20 times for  journals. The petition was filed in December, 2011 and approved several days later.

EB1A-23: The petitioner/beneficiary was an atmospheric scientist at a US National Laboratory. When the petition was filed, he published about 20 research papers. These publications were widely cited by others. The petitioner reviewed about 20 times for multiple journals. The petition was filed in November 2011, and approved several days later.

EB1A-22: The petitioner/beneficiary was a research scientist at a US university. When the petition was filed, she published about 20 research papers, half of them in non-English journals. These publications were modestly cited. The petitioner won a national award in a foreign country. The petition was filed in August 2011 and approved in October 2011.

EB1A-21: The petitioner/beneficiary was a tenure-track Assistant Professor and computer scientist at a US university. When the petition was filed, she published nine journal and conference papers which were widely cited by others. The petitioner was frequently invited to serve as a reviewer for journals and conferences. The petition was filed in August 2011, and approved several days later.

EB1A-20: The petitioner/beneficiary was a research Assistant Professor at a US medical school. He obtained PhD in a foreign country. When the petition was filed, the petitioner published about 20 research articles; some of the publications were substantially cited by others. The petitioner also served a reviewer for several journals. The petition was filed in August 2011, and approved about 10 days later.

EB1A-19: The petitioner/beneficiary was a tenure-track Assistant Professor of Computer Science at a US university. When the case was filed, the petitioner published over 30 research articles which were cited about 100 times. The petitioner was frequently invited to review research manuscripts for journals and conferences. The petition was filed in July 2011 and approved several days later.

EB1A-18: The petitioner/beneficiary was a medical scientist in the United States. He received MS from a US college. When the case was filed, the petitioner published six original research articles, reviewed over 20 times for several international journals and accumulated over 80 independent citations to his work. The petition was filed in May 2011, and approved several days later.

EB1A-17: The petitioner/beneficiary was an Assistant Professor of Computer Science at a US university. He published 35 original research articles that were cited over 1000 times. He also frequently reviewed research manuscripts for journals/conferences. The petition was filed in April 2011, and approved in May 2011.

EB1A-16: The petitioner/beneficiary was a medical scientist working at a US non-profit organization. She obtained PhD in a foreign country and published 17 research articles in her academic career. She also reviewed about 20 times for different journals and was a member of the Editorial Board of a journal. The petition was filed in March 2011 and approved in April 2011.

EB1A-15:  The petitioner/beneficiary was a computer scientist in the United States. He published about 20 research articles that were widely cited by others. The petitioner also reviewed many research manuscripts for journals and international conferences. He won two prestigious fellowships (many winners of these fellowships became NAS or NAE members, or even won Noble Prizes). The petition was filed in January 2011 and approved several days later with the request of premium processing service.

EB1A-14:  The petitioner/beneficiary obtained PhD in medical sciences from a foreign country. He published over 40 research articles that were widely cited by others. He also won a national award in his home country. The petition was filed in August 2010 and approved in February 2011 (with the request of premium processing service after pending for over three months).

EB1A-13: The petitioner/beneficiary was a PhD graduate of a US university. She published ten original medical research articles, four of them in international journals. The petitioner's work was widely cited by others. The petitioner also reviewed research manuscripts for four different journals. The petition was filed in February 2011 and approved several days later with the request of premium processing service.

EB1A-12:  The petitioner/beneficiary was a structural biologist and worked as a specialist at a US public university. When the petition was filed, the petitioner published 16 research articles that were widely cited by others. The petitioner also served as a judge of the work of others. The petition was approved 10 days after filing and with the request of premium processing service. No RFE.

EB1A-11:  The petitioner/beneficiary was an Assistant Professor at a US public university, specializing in Electrical Engineering. He published around 40 journal and conference papers. He also won a national award in the United States. However, the petitioner's publication were minimally cited by others. The petition was approved 12 days after the filing and with the request of premium processing service. No RFE.

EB1A-10:  The petitioner/beneficiary was a theoretical chemist. He published about 40 original research articles which were widely cited by others. The petition was approved 10 days after filing, with the request of premium processing service. No RFE.

EB1A-9:  The petitioner/beneficiary was a biochemist. He won two national awards in a foreign country and published many research articles which were widely cited by others. The petition was approved 10 days after filing. No RFE.

EB1A-8: the alien was a computer scientist and worked at a US research university as a postdoctoral fellow. He published three journal articles and several conference papers. All the publications were cited by others for around 80 times. The alien served as a referee for several journals and several conferences. The petition was approved 10 days after filing. No RFE.

EB1A-7:  The petitioner/beneficiary was an epidemiologist and worked for a US Federal government agency. She played a leading and critical role in a Federal program. She also published multiple research articles that were widely cited by others and reviewed research manuscripts for several journals. The petition was approved three months after filing. No RFE.

EB1A-6:  The petitioner/beneficiary was a climate scientist and earned PhD in the United States. When the petition was filed, he published around 40 research articles. These articles were cited about 660 times.  The petitioner/beneficiary also provided review services for about 10 professional journals. The petition was approved three weeks after filing. No RFE.

EB1A-5:  The petitioner/beneficiary was a food scientist. When the petition was filed, she published eight research articles. These articles were cited about 110 times.  The petitioner/beneficiary reviewed over 20 times for different journals. Three months after filing, this petition was approved without RFE.

EB1A-4:  The petitioner/beneficiary was a medical scientist. When the petition was filed, the client published 30 research articles. The client's work was cited for a total of 280 times. The petition was approved seven days after  filing.

EB1A-3:  The petitioner/beneficiary earned PhD degree in Materials Science in a foreign country and published over 30 research articles. These articles were cited about 80 times. The alien reviewed over 100 times for many different journals. The petition was approved three weeks after filing. No RFE.

EB1A-2:  The petitioner/beneficiary was a medical scientist and earned PhD degree in the United States. When the petition was filed, she published two research articles, which were cited for around 50 times. One article was highlighted on major news media. The petition was approved four weeks after filing. No RFE.

EB1A-1:  The petitioner/beneficiary was a medical scientist and earned PhD in the United States. When the petition was filed, he published five research articles. Some of the articles were highlighted in professional publications. The articles were cited for a total of 160 times. The petition was approved four weeks after filing. No RFE.